Bruce & Co., Inc.
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 13, 2024), Bruce & Co., Inc. reported 37 stock positions worth $297.1 million. Its top holding was U-Haul Holding Co.-Non Voting (UHAL.B) at 11.1% of the portfolio, followed by Merck (MRK, 9.8%) and Abbvie (ABBV, 8.5%). Compared with Q4 2023, it opened 2 new positions, added to 2 and reduced 3. The biggest buy was a new position in Bunge Global (BG) and the biggest sale Xcel Energy (XEL, shares −34%).
- Most Recent 13F
- Q2 2026
- Location
- CHICAGO, IL
- CIK
- 0001358331
- Portfolio Value
- $297.1M (Q1 2024)
- SEC Filing
- 0001104659-24-060446 ↗ filed May 13, 2024
Holdings Value
Holdings 37 stocks · $297.1M
| UHAL.B U-Haul Holding Co.-Non Voting | 11.07% | 493,350 | $32.9M | Reduce -8.0% |
| MRK Merck & Co Inc | 9.80% | 220,700 | $29.1M | No change |
| ABBV Abbvie Inc. | 8.46% | 138,000 | $25.1M | No change |
| ALL Allstate Corp. | 7.41% | 127,200 | $22.0M | No change |
| DUK Duke Energy Corp. | 6.64% | 203,890 | $19.7M | No change |
| CMS CMS Energy Corp. | 6.42% | 316,000 | $19.1M | No change |
| Nextera Energy filed as FPL GROUP INC | 6.32% | 293,600 | $18.8M | No change |
| ABT Abbott Laboratories | 5.74% | 150,000 | $17.0M | No change |
| T AT&T Inc. | 5.69% | 961,000 | $16.9M | No change |
| IIIN Insteel Industries Inc. | 4.42% | 343,423 | $13.1M | No change |
| XEL Xcel Energy Inc. | 3.49% | 193,000 | $10.4M | Reduce -34.1% |
| PFE Pfizer Inc. | 2.51% | 268,500 | $7.5M | No change |
| AVA Avista Corp. | 2.37% | 201,500 | $7.1M | No change |
| DAR Darling Ingredients Inc. | 2.35% | 150,000 | $7.0M | Add +7.1% |
| VALEANT PHARMACEUTICALS INTL filed as Bausch Health | 2.30% | 644,000 | $6.8M | No change |
| AAPL Apple Inc. | 2.03% | 35,100 | $6.0M | No change |
| BG Bunge Global SA | 1.73% | 50,000 | $5.1M | New |
| UHAL U-Haul Holding Co. | 1.61% | 70,805 | $4.8M | No change |
| FOCL Edap TMS SA -ADR | 1.37% | 553,652 | $4.1M | No change |
| ADM Archer-Daniels-Midland Co. | 1.06% | 50,000 | $3.1M | New |
| SUPN Supernus Pharmaceuticals Inc. | 0.94% | 82,105 | $2.8M | No change |
| LVTX Lava Therapeutics NV | 0.86% | 771,874 | $2.6M | No change |
| NEM Newmont Corp. | 0.79% | 65,600 | $2.4M | No change |
| KOD Kodiak Sciences Inc. | 0.75% | 423,000 | $2.2M | Reduce -10.6% |
| SIRI Sirius XM Holdings Inc. | 0.73% | 557,843 | $2.2M | No change |
| VICR Vicor Corp. | 0.58% | 45,000 | $1.7M | Add +50.0% |
| ASH Ashland LLC | 0.49% | 15,000 | $1.5M | No change |
| FATE Fate Therapeutics Inc. | 0.35% | 143,000 | $1.0M | No change |
| CRBU Caribou Biosciences Inc. | 0.35% | 200,000 | $1.0M | No change |
| MNKD Mannkind Corp. | 0.30% | 195,073 | $884K | No change |
| VTRS Viatris Inc. | 0.23% | 58,252 | $696K | No change |
| IGMS Igm Biosciences Inc. | 0.21% | 65,000 | $627K | No change |
| OGN Organon & Co. | 0.20% | 31,190 | $586K | No change |
| MASS 908 Devices Inc. | 0.17% | 68,286 | $516K | No change |
| PSNL Personalis Inc. | 0.15% | 300,000 | $447K | No change |
| RLI Rli Corp. | 0.10% | 2,000 | $297K | No change |
| WBD Warner Bros Discovery Inc. | 0.03% | 10,642 | $93K | No change |
Other holdings (2): bonds, preferreds, convertibles and warrants · $4.4M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| Acorda Theraputics | Cv 6.0% · principal | 5,000,000 | $2.9M | No change |
| ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26) | NOTE 5.000%12/1 · principal | 3,133,920 | $1.5M | No change |
Total filed on the 13F, all lines: $301.5M.
Portfolio Sells Q4 2023 → Q1 2024
Portfolio Buys Q4 2023 → Q1 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 41 | $369.5M | ABBV, ALL, AER, Nextera Energy, MRK |
| Q1 2026 | 41 | $349.7M | Nextera Energy, ABBV, ALL, AER, MRK |
| Q4 2025 | 39 | $322.5M | ABBV, AER, ALL, Nextera Energy, UHAL.B |
| Q3 2025 | 39 | $322.9M | ABBV, ALL, Nextera Energy, UHAL.B, AER |
| Q2 2025 | 40 | $307.8M | ALL, UHAL.B, ABBV, Nextera Energy, AER |
| Q1 2025 | 41 | $310.5M | UHAL.B, ABBV, ALL, Nextera Energy, DUK |
| Q4 2024 | 39 | $309.9M | UHAL.B, ALL, ABBV, Nextera Energy, MRK |
| Q3 2024 | 39 | $342.1M | UHAL.B, ABBV, Nextera Energy, ALL, MRK |
| Q2 2024 | 38 | $299.2M | UHAL.B, MRK, ABBV, Nextera Energy, ALL |
| Q1 2024 | 37 | $297.1M | UHAL.B, MRK, ABBV, ALL, DUK |